Nov 19

Past Event

New Policy Directions for Biomedical Innovation

Event Materials




Brookings Multimedia content requires JavaScript. Your browser either doesn't have JavaScript or doesn't have it enabled.

Instructions to enable JavaScript.


On November 19, the Engelberg Center for Health Care Reform at Brookings hosted an event examining the outlook and opportunities for biomedical innovation in a challenging fiscal environment. Leaders in the field offered their thoughts on future directions of and policy priorities for the innovation enterprise. Following a brief keynote, a panel of senior thought leaders provided further discussion on actionable next steps to improve biomedical innovation.

Download the executive summary » (PDF)
Download the panelist biographies » (PDF)

Event Agenda

  • 1:30


  • 1:45

    Priorities for Biomedical Innovation in a Challenging Fiscal Environment

  • 2:25

    Finding the Path Forward for Biomedical Innovation

    • Moderator

    • Christopher Austin


      National Center for Advancing Translational Sciences

    • Deborah Brooks

      Co-Founder and Executive Vice Chairman

      The Michael J. Fox Foundation

    • Robert Conley

      Regulatory Leader and Distinguished Lilly Scholar

      Eli Lilly and Company

    • John Mendelsohn

      Professor, Department of Experimental Therapeutics, Division of Cancer Medicine and Director, Khalifa Institute for Personalized Cancer Therapy

      The University of Texas MD Anderson Cancer Center

    • Earl Steinberg

      Executive Vice President of Innovation & Dissemination

      Geisinger Health Solutions

  • 3:20

    Closing Remarks


November 19, 2012

1:30 PM - 3:30 PM EST

Brookings Institution

Saul/Zilkha Rooms

1775 Massachusetts Avenue NW


For More Information

Brookings Office of Communications